Structure |
Chemical Name |
CAS |
MF |
|
9-(2,5-d|Dioxo-L-3-aMino-1-pyrrolidineacetic acid)-10-deglycine DaptoMycin |
121869-35-0 |
C72H99N17O25 |
|
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine |
38284-47-8 |
C17H31NO2 |
|
[4-(4-AMino-6-hydroxy-7-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone |
105356-89-6 |
C18H23N5O4 |
|
2,2'-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-Methyl-5-thiazolecarboxylic Acid 5,5'-DiMethyl Ester |
1330632-47-7 |
C22H24N2O5S2 |
|
2-(DiethylaMino)-N-(2,4-diMethylphenyl)acetaMide Hydrochloride |
17289-54-2 |
C14H23ClN2O |
|
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine |
641571-16-6 |
C11H10F3N3 |
|
4-[[3-(4-Methylphenyl)-3-oxo-1-(trifluoroMethyl)propylidene]aMino]benzenesulfonaMide |
1061214-09-2 |
C17H15F3N2O3S |
|
5-(Ethoxycarbonyl)-2-(hydroxyMethyl-6-Methyl-4-(3-nitrophenyl)nicotinic Acid |
89267-43-6 |
C17H16N2O7 |
|
9-L-β-Aspartic acid-daptoMycin |
123180-72-3 |
C72H101N17O26 |
|
Chlorhexidine Digluconate IMpurity K |
1381962-77-1 |
C22H29Cl2N9O |
|
Cyclopropyl 3-Fluorobenzyl Ketone |
952722-64-4 |
C11H11FO |
|
Linear DaptoMycin |
883991-21-7 |
C72H103N17O27 |
|
N,N-DiMethylaMidino) Urea |
98026-16-5 |
C4H10N4O |
|
rac Dehydro-O-desMethyl Venlafaxine |
1346600-38-1 |
C16H23NO |
|
3-HYDROXY DESLORATADINE HCL |
119410-08-1 |
C19H19ClN2O |
|
Vinorelbine N'b-Oxide Sulfate Salt |
74075-34-6 |
C45H54N4O9 |
|
Linagliptin iMpurity G |
668270-11-9 |
C25H28N8O2 |
|
Tadalafil EP IMpurity F |
|
|
|
(2R,3R,4R,5S)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-fluoro-4-Methyltetrahydrofuran-3-yl benzoate |
874638-94-5 |
C31H26FN3O7 |
|
CefuroxiMe sodiuM iMpurity B |
|
C16H16N4NaO8S |
|
Fasudil N-hydroxy iMpurity |
1350827-92-7 |
C14H17N3O3S |
|
TaMsulosin IMpurity A |
|
C20H28N2O5S |
|
4-[4-(diMethylaMino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxyMethyl)-benzonitrile (CitalopraM Olefinic IMpurity) |
920282-75-3 |
C20H21FN2O |
|
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl Acetate |
844639-07-2 |
C23H27N3O3S |
|
4-O-DesMethyl 4-O-Ethyl TriMethopriM |
78025-68-0 |
C15H20N4O3 |
|
1-[[(2E)-3-Phenyl-2-propen-1-yl]oxy]naphthalene |
1091626-77-5 |
C19H16O |
|
α-[[[2-(4-Methoxyphenyl)-1-Methylethyl](phenylMethyl)aMino]Methyl]-3-nitro-4-(phenylMethoxy)benzeneMethanol |
43229-67-0 |
C32H34N2O5 |
|
Indacaterol IMrity |
1235445-80-3 |
C24H28N2O3 |
|
Topiroxostat IMpurity |
|
|
|
Flurbiprofen Impurity 17 |
1206101-29-2 |
C24H16F2 |
|
1,2-Bis(piperazin-1-yl)benzene |
1446750-99-7 |
C14H22N4 |
|
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid |
417721-34-7 |
C11H9NO4 |
|
Pemetrexed |
|
|
|
Venlafaxine |
|
C17H27NO2 |
|
(S)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxoMorpholino)phenyl)oxazolidin-5-yl)Methyl)thiophene-2-carboxaMide |
1770812-37-7 |
C19H17Cl2N3O5S |
|
2-Propen-1-one, 1-[4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]-1-piperidinyl]- |
936563-92-7 |
C25H24N6O2 |
|
8-cyclopentyl-5-Methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)aMino)-6-vinylpyrido[2,3-d]pyriMidin-7(8H)-one |
|
C24H29N7O |
|
D-Alanine, N-[[P(R),2'R]-2'-deoxy-2'-fluoro-2'-Methyl-P-phenyl-5'-uridylyl]-, 1-Methylethyl ester |
1496552-16-9 |
C22H29FN3O9P |
|
D-Phenylalanine, N-[(1,1-diMethylethoxy)carbonyl]-L-leucyl-, Methyl ester |
15136-32-0 |
C21H32N2O5 |
|
4-Nitro-2-phenoxyphenol |
70995-08-3 |
C12H9NO4 |
|
Sofosbuvir Impurity |
1233335-82-4 |
C16H25FN3O9P |
|
Ethyl 3,4-O-isopropylideneshikiMate |
136994-78-0 |
C12H18O5 |
|
4-Vinyl-piperidine-4-carboxylic acid ethyl ester |
1509910-91-1 |
C10H17NO2 |
|
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid |
1039307-95-3 |
C18H21NO2 |
|
EMpagliflozin iMpurity 16 |
|
|
|
((R)-2-biphenyl-4-yl-1-forMylethyl)carbaMic acid t-butyl ester |
149709-58-0 |
C20H23NO3 |
|
1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol |
86347-12-8 |
C13H16N2O |
|
(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
1612153-32-8 |
C20H20FNO4 |
|
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
|
Posaconazole iMpurity 3 |
|
|
|
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
|
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
|
Ezetimibe Related Impurity 37 |
204589-68-4 |
C24H19F2NO2 |
|
S, R-Isovalganciclovir Impurity |
1356932-18-7 |
C14H22N6O5 |
|
Sofosbuvir Impurity 8 |
944476-44-2 |
C24H22N2O8 |
|
1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid |
1098100-87-8 |
C26H23N3O2 |
|
Fimasartan Impurity |
|
|
|
2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid |
|
C21H20FN3O6S |
|
2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE |
17289-53-1 |
C14H22N2O |
|
(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
C16H20N2O |
|
Oxaliplatin impurity |
|
|
|
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
|
Moxifloxacin Impurities |
|
|
|
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
|
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
|
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
|
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
|
Etoricoxib Impurity 14 |
|
|
|
Riociguat Impurtiy 3 |
|
|
|
Trelagliptin Impurity 2 |
|
|
|
Chlorhexidine Impurity B |
1308292-89-8 |
C16H26ClN9O |
|
Dapoxetine Impurity D |
|
|
|
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
|
Lidocaine Impurity |
35891-84-0 |
C11H16N2O.ClH |
|
Pramipexole Impurity J |
|
|
|
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
|
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
|
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
|
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
|
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
|
Silodosin impurity A |
|
|
|
cefditoren △-3 isomer |
|
|
|
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
|
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
|
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
|
Tofacitinib Impurity L |
|
|
|
1-chloro-3-(dimethoxymethyl)benzene |
3395-80-0 |
C9H11ClO2 |
|
N-(3-bromo-4-oxocyclohexyl)acetamide |
687639-03-8 |
C8H12BrNO2 |
|
methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C44H51N9O4 |
|
Alvimopan Impurity 5 |
|
|
|
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
|
Ivabradine Impurity 15 |
1132667-04-9 |
C12H17NO2 |
|
Sofosbuvir Impurity27 |
|
|
|
Isavuconazole Impurity 12 |
|
|
|
Tacrolimus Impurity 3 |
161861-10-5 |
C45H71NO13 |
|
Bisoprolol EP Impurity J |
1797024-50-0 |
C15H24O5 |
|
Ceftriaxone Impurity |
79221-95-7 |
C18H18N8O8S3 |
|
Betaxolol EP Impurity E |
1329613-85-5 |
C18H31NO3 |
|
Tulobuterol Impurity |
34356-83-7 |
C8H5Br2ClO |
|
Olaparib Impurity A |
|
|